0001209191-24-002897.txt : 20240206
0001209191-24-002897.hdr.sgml : 20240206
20240206130817
ACCESSION NUMBER: 0001209191-24-002897
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240206
DATE AS OF CHANGE: 20240206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schatzman Randall C
CENTRAL INDEX KEY: 0001604763
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39988
FILM NUMBER: 24599340
MAIL ADDRESS:
STREET 1: 11804 NORTH CREEK PARKWAY SOUTH
CITY: BOTHELL
STATE: WA
ZIP: 98011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bolt Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001641281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472804636
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-665-9295
MAIL ADDRESS:
STREET 1: 900 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: Bolt Therapeutics, Inc.
DATE OF NAME CHANGE: 20150504
5
1
doc5.xml
FORM 5 SUBMISSION
X0508
5
2023-12-31
0
0
0
0001641281
Bolt Biotherapeutics, Inc.
BOLT
0001604763
Schatzman Randall C
C/O BOLT BIOTHERAPEUTICS, INC.
900 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-06-06
5
P
0
2500
1.1815
A
10359
D
Common Stock
2023-12-06
5
P
0
2500
0.782
A
12859
D
Shares acquired under the issuer's Employee Stock Purchase Plan.
/s/ William P. Quinn, Attorney-in-Fact
2024-02-06